Litcius/Paper detail

Managing risk from conflicts of interest in guideline development committees

Lisa Parker, Lisa Bero

2022BMJ16 citationsDOI

Abstract

<b>Lisa Parker</b> and <b>Lisa Bero</b> argue that we need transparent tailored criteria to assess and respond to potential bias created by guideline committee members with conflicts of interest

Topics & Concepts

GuidelineConflict of interestMedicineComputer sciencePolitical scienceLawPathologyPharmaceutical industry and healthcareHealthcare cost, quality, practicesGlobal Public Health Policies and Epidemiology
Managing risk from conflicts of interest in guideline development committees | Litcius